Clinical Trial Update: Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dose-escalated proton radiation therapy for high-risk prostate cancer (Phase 2, status: active but not recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Florida | Conditions: Adenocarcinoma of the Prostate | Phase 2 | Status: ACTIVE_NOT_RECRUITING